Amansa Investments Pumps Rs 250 Crore In Rubicon Research In Pre-IPO Funding Round

Amansa Investments Completes ₹250 Crore Pre-IPO Placement in Rubicon Research Reducing IPO Fresh Issue Size

Amansa Investments has finalized a ₹250 crore pre-IPO p […] The post Amansa Investments Completes ₹250 Crore Pre-IPO Placement in Rubicon Research Reducing IPO Fresh Issue Size first appeared on GeneOnline News. The post Amansa Investments Completes ₹250 Crore Pre-IPO Placement in Rubicon Research Reducing IPO Fresh Issue Size appeared first on GeneOnline News.

Amansa Investments completes ₹250 crore pre-IPO placement in Rubicon Research - Express Pharma

Amansa Investments has invested ₹250 crore in Rubicon Research Limited through a pre-IPO placement. Corporate Promoter General Atlantic Singapore RR Pte transferred 51,60,278 equity shares, each with a face value of Re. 1, to Amansa Investments at a price of ₹484.47 per share, including a share premium of ₹483.47 per share. The total transaction value aggregated to ₹250 crore. The transaction, conducted in consultation with the Book Running Lead…

Amansa Investments Pumps Rs 250 Crore In Rubicon Research In Pre-IPO Funding Round

Amansa Investments Ltd has invested Rs 250 crore in pharma formulation firm Rubicon Research Ltd through a pre-initial public offering funding round.As part of the transaction, General Atlantic Singapore RR Pte Ltd, one of Rubicon Research's promoters, transferred 51.60 lakh equity shares to Amansa Investments at Rs 484.47 per share, amounting to Rs 250 crore, the company said in a public announcement.At the time of filing draft papers in July 2…